Bukwang Pharm Co Ltd
KRX:003000

Watchlist Manager
Bukwang Pharm Co Ltd Logo
Bukwang Pharm Co Ltd
KRX:003000
Watchlist
Price: 3 945 KRW 2.47% Market Closed
Market Cap: ₩389.2B

Operating Margin

4.3%
Current
Improving
by 12.6%
vs 3-y average of -8.3%

Operating Margin shows how much profit a company makes from its regular business activities after covering operating costs. It helps measure how efficiently the company turns sales into profit.

Operating Margin
4.3%
=
Operating Income
₩8B
/
Revenue
₩184.4B

Operating Margin shows how much profit a company makes from its regular business activities after covering operating costs. It helps measure how efficiently the company turns sales into profit.

Operating Margin
4.3%
=
Operating Income
₩8B
/
Revenue
₩184.4B

Peer Comparison

Country Company Market Cap Operating
Margin
KR
Bukwang Pharm Co Ltd
KRX:003000
389.2B KRW
Loading...
US
Eli Lilly and Co
NYSE:LLY
1T USD
Loading...
UK
Dechra Pharmaceuticals PLC
F:1PK
5.1B EUR
Loading...
US
Johnson & Johnson
NYSE:JNJ
528.7B USD
Loading...
CH
Roche Holding AG
SIX:ROG
275.3B CHF
Loading...
UK
AstraZeneca PLC
LSE:AZN
210.3B GBP
Loading...
DK
Novo Nordisk A/S
CSE:NOVO B
1.8T DKK
Loading...
CH
Novartis AG
SIX:NOVN
221.9B CHF
Loading...
US
Merck & Co Inc
NYSE:MRK
267.9B USD
Loading...
IE
Endo International PLC
LSE:0Y5F
218B USD
Loading...
US
Pfizer Inc
NYSE:PFE
145.6B USD
Loading...

Market Distribution

In line with most companies in Korea
Percentile
60th
Based on 2 615 companies
60th percentile
4.3%
Low
-163 055.6% — -2.2%
Typical Range
-2.2% — 6.8%
High
6.8% — 22 874.8%
Distribution Statistics
Korea
Min -163 055.6%
30th Percentile -2.2%
Median 2.7%
70th Percentile 6.8%
Max 22 874.8%

Bukwang Pharm Co Ltd
Glance View

Market Cap
389.2B KRW
Industry
Pharmaceuticals

Bukwang Pharmaceutical Co., Ltd. engages in the manufacture and sale of pharmaceutical products. The company is headquartered in Seoul, Seoul. The firm operates its business through two segments. The Medicines and Quasi-drugs segment mainly produces and distributes pharmaceutical products including antidiabetic agents, anemic medicines, thyroid parathyroid hormone drugs, antihistamines, epileptic drugs, bronchodilators, stomatitis drugs, anti-malignant tumors, gum nutrition, hepatitis treatments, targeted anticancer agents, and others. The Research and Development segment mainly researches and develops pharmaceutical products.

Bukwang Pharm Co Ltd Intrinsic Value
HIDDEN
Show
What is Operating Margin?
Operating Margin shows how much profit a company makes from its regular business activities after covering operating costs. It helps measure how efficiently the company turns sales into profit.
How is Operating Margin calculated?

Operating Margin is calculated by dividing the Operating Income by the Revenue.

Operating Margin
4.3%
=
Operating Income
₩8B
/
Revenue
₩184.4B
What is Bukwang Pharm Co Ltd's current Operating Margin?

The current Operating Margin for Bukwang Pharm Co Ltd is 4.3%, which is above its 3-year median of -8.3%.

How has Operating Margin changed over time?

Over the last 3 years, Bukwang Pharm Co Ltd’s Operating Margin has increased from 0.8% to 4.3%. During this period, it reached a low of -30.4% on Jun 30, 2024 and a high of 5.7% on Jun 30, 2025.

Back to Top